Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Uterine Cervix”

144 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 144 results

Testing effectiveness (Phase 2)Looking for participantsNCT06654011
What this trial is testing

IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial

Who this might be right for
Cervical AdenocarcinomaGastric-type Endocervical Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 25
Not applicableUnknownNCT01649089
What this trial is testing

Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+4 more
GOG Foundation 224
Early research (Phase 1)Study completedNCT02164461
What this trial is testing

Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer

Who this might be right for
Effects of ImmunotherapyMetastatic/Recurrent Cervical CancerCervical Adenocarcinoma+6 more
Advaxis, Inc. 12
Early research (Phase 1)Study completedNCT01711515
What this trial is testing

Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+6 more
National Cancer Institute (NCI) 34
Not applicableUnknownNCT03742869
What this trial is testing

HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma

Who this might be right for
Cervical AdenocarcinomaHuman PapillomavirusGenome-wide Association Study+5 more
Lei Li 40
Testing effectiveness (Phase 2)Study completedNCT00003379
What this trial is testing

Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 40
Testing effectiveness (Phase 2)Study completedNCT01590017
What this trial is testing

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerAcquired Immunodeficiency Syndrome
AIDS Malignancy Consortium 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06805864
What this trial is testing

Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous Carcinoma
Gunma University 45
Testing effectiveness (Phase 2)WithdrawnNCT01301612
What this trial is testing

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Who this might be right for
CarcinomaAdenocarcinomaUterine Cervix Adenosquamous Carcinoma
Eurofarma Laboratorios S.A.
Not applicableUnknownNCT01074424
What this trial is testing

Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 84
Early research (Phase 1)Study completedNCT00003377
What this trial is testing

Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 29
Testing effectiveness (Phase 2)Looking for participantsNCT07276360
What this trial is testing

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Who this might be right for
Cervical CancerCervix CancerCervical Adenocarcinoma+2 more
Uganda Cancer Institute 278
Early research (Phase 1)UnknownNCT01295502
What this trial is testing

Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+6 more
Gynecologic Oncology Group 45
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT00039442
What this trial is testing

Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma
Gynecologic Oncology Group 21
Testing effectiveness (Phase 2)Study completedNCT00057863
What this trial is testing

Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT03738228
What this trial is testing

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+8 more
National Cancer Institute (NCI) 40
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Early research (Phase 1)Study completedNCT01281852
What this trial is testing

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
National Cancer Institute (NCI) 37
Next Page